January 27, 2015 9:47 AM ET


Company Overview of Aton Pharma, Inc.

Company Overview

Aton Pharma, Inc. is a pharmaceutical company that provides medicines to patients worldwide. It offers medically essential treatments for serious and life-threatening medical conditions. The company focuses on the ophthalmic and orphan drug markets. Its marketed products include Mephyton, Edecrin, Sodium Edecrin, Cuprimine, Syprine, Demser, and Lodosyn for orphan diseases; and Lacrisert, Timoptic, Timoptic-XE, and Timoptic in Ocudose for ophthalmic diseases. The company also focuses on developing indications for ophthalmic therapeutics and novel therapeutics for rare diseases, which comprise injectable vitamin k for anticoagulation disorders; low-dose vitamin k to treat non-therapeutic INRs;...

3150 Brunswick Pike

Suite 230

Lawrenceville, NJ 08648

United States

Founded in 2001





Key Executives for Aton Pharma, Inc.

Vice President of Commercial Operations - Ophthalmic Business Unit
Vice President of Commercial Operations - Orphan Drug Business Unit
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Humanetics Corporation United States
CerRx Inc. United States
Acupac Packaging, Inc. United States
Bryce Rx Laboratories, Inc. United States
Legacy Pharmaceuticals Puerto Rico, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Aton Pharma, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.